Work

A randomized, phase II trial of adjuvant immunotherapy with durable TKI-free survival in patients with chronic phase CML

Year: 2021

Type: article

Study design: Clinical Trial

Source: Leukemia Research

DOI: 10.1016/j.leukres.2021.106737

Authors: Jonathan A. Webster, Tara M. Robinson, Amanda L. Blackford, Erica Warlick, Anna Ferguson, Ivan Borrello, Marianna Zahurak, Richard J. Jones, B. Douglas Smith

Institutions: Johns Hopkins University, Johns Hopkins Medicine, BioMarin (United States), University of Minnesota

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: Bone Marrow Transplantation in Human Disease, Regional Oncology Research Center

OpenAlex ID: W3209701332

FWCI: 0.655

Cites: 41

Cited by: 8

Related to: 10